EE37 Cost-Utility Analysis of Elecsys Gaad Algorithm Versus Ultrasound Plus -Fetoprotein (AFP) for HCC Surveillance in Patients With Compensated Liver Cirrhosis in the United Kingdom (UK)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.290
https://www.valueinhealthjournal.com/article/S1098-3015(22)02494-9/fulltext
Title :
EE37 Cost-Utility Analysis of Elecsys Gaad Algorithm Versus Ultrasound Plus -Fetoprotein (AFP) for HCC Surveillance in Patients With Compensated Liver Cirrhosis in the United Kingdom (UK)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02494-9&doi=10.1016/j.jval.2022.09.290
First page :
Section Title :
Open access? :
No
Section Order :
12098